HellaWell
Innovation Pipeline
HellaWell bridges the gap between clinical systems biology and commercial wellness. Our strategic fit for Unilever's Open Innovation program is built on a rigorous, multi-phase protocol that prioritizes hormonal balance and cellular resilience for women at every life stage.
PHASE 1: SYSTEMS BIOLOGY
Deep-dive genomic analysis to identify metabolic pathways and hormonal imbalances that drive long-term wellness outcomes.
PHASE 2: CELLULAR PROTOCOLS
Development of proprietary cellular wellness protocols designed to optimize endocrine function and immune-biome health.
PHASE 3: MARKET STRATEGY
Strategic commercialization and institutional investment frameworks for scaling biological wellness across global markets.
Pitch Decks & Protocols
Comprehensive technical white papers and investor decks for the Open Innovation program.
Women's Systems Biology
Endocrine Wellness White Paper
